Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Myotonic Dystrophy Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
F Hoffmann-La Roche Ltd
Valentia Biopharma SL
BioMarin Pharmaceutical Inc
Genzyme Corporation
Isis Pharmaceuticals, Inc
By Type:
ISIS-DMPKRx
PRO-135
Others
SRT-152
VAL-0411
By Application:
Hospital
Home Use
Clinic
Others
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Myotonic Dystrophy Drug Market Overview 2018-2029
-
1.1 China Myotonic Dystrophy Drug Industry Development Overview
-
1.2 China Myotonic Dystrophy Drug Industry Development History
-
1.3 China Myotonic Dystrophy Drug Industry Market Size (2018-2029)
-
1.4 China Myotonic Dystrophy Drug Market Analysis by Type from Production Side
-
1.4.1 China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of ISIS-DMPKRx (2018-2029)
-
1.4.2 China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of PRO-135 (2018-2029)
-
1.4.3 China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.4 China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of SRT-152 (2018-2029)
-
1.4.5 China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of VAL-0411 (2018-2029)
-
1.5 China Myotonic Dystrophy Drug Market Analysis by Application from Consumption End
-
1.5.1 China Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate of Home Use (2018-2029)
-
1.5.3 China Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.4 China Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.6 China Myotonic Dystrophy Drug Market Analysis by Region
-
1.6.1 North China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Myotonic Dystrophy Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Myotonic Dystrophy Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Myotonic Dystrophy Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Myotonic Dystrophy Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Myotonic Dystrophy Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Myotonic Dystrophy Drug Industry Development
Chapter 3 Myotonic Dystrophy DrugIndustry Chain Analysis
-
3.1 Myotonic Dystrophy Drug Industry Chain
-
3.2 Myotonic Dystrophy Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Myotonic Dystrophy Drug Market
-
3.3 Myotonic Dystrophy Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Myotonic Dystrophy Drug Market
Chapter 4 China Myotonic Dystrophy Drug Market, by Type
-
4.1 China Myotonic Dystrophy Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Myotonic Dystrophy Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Myotonic Dystrophy Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Myotonic Dystrophy Drug Production Volume and Growth Rate of ISIS-DMPKRx
-
4.5.2 China Myotonic Dystrophy Drug Production Volume and Growth Rate of PRO-135
-
4.5.3 China Myotonic Dystrophy Drug Production Volume and Growth Rate of Others
-
4.5.4 China Myotonic Dystrophy Drug Production Volume and Growth Rate of SRT-152
-
4.5.5 China Myotonic Dystrophy Drug Production Volume and Growth Rate of VAL-0411
Chapter 5 China Myotonic Dystrophy Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Myotonic Dystrophy Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Myotonic Dystrophy Drug Market Size and Growth Rate, by Application
-
5.5.1 China Myotonic Dystrophy Drug Market Size and Growth Rate of Hospital
-
5.5.2 China Myotonic Dystrophy Drug Market Size and Growth Rate of Home Use
-
5.5.3 China Myotonic Dystrophy Drug Market Size and Growth Rate of Clinic
-
5.5.4 China Myotonic Dystrophy Drug Market Size and Growth Rate of Others
Chapter 6 China Myotonic Dystrophy Drug Market, by Region
-
6.1 China Myotonic Dystrophy Drug Production Volume and Production Value, by Region
-
6.2 China Myotonic Dystrophy Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Myotonic Dystrophy Drug Market Analysis
-
7.1 North China Myotonic Dystrophy Drug Market, by Type
-
7.2 North China Myotonic Dystrophy Drug Market, by Application
Chapter 8 Central China Myotonic Dystrophy Drug Market Analysis
-
8.1 Central China Myotonic Dystrophy Drug Market, by Type
-
8.2 Central China Myotonic Dystrophy Drug Market, by Application
Chapter 9 South China Myotonic Dystrophy Drug Market Analysis
-
9.1 South China Myotonic Dystrophy Drug Market, by Type
-
9.2 South China Myotonic Dystrophy Drug Market, by Application
Chapter 10 East China Myotonic Dystrophy Drug Market Analysis
-
10.1 East China Myotonic Dystrophy Drug Market, by Type
-
10.2 East China Myotonic Dystrophy Drug Market, by Application
Chapter 11 Northeast China Myotonic Dystrophy Drug Market Analysis
-
11.1 Northeast China Myotonic Dystrophy Drug Market, by Type
-
11.2 Northeast China Myotonic Dystrophy Drug Market, by Application
Chapter 12 Southwest China Myotonic Dystrophy Drug Market Analysis
-
12.1 Southwest China Myotonic Dystrophy Drug Market, by Type
-
12.2 Southwest China Myotonic Dystrophy Drug Market, by Application
Chapter 13 Northwest China Myotonic Dystrophy Drug Market Analysis
-
13.1 Northwest China Myotonic Dystrophy Drug Market, by Type
-
13.2 Northwest China Myotonic Dystrophy Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 F Hoffmann-La Roche Ltd
-
14.1.1 F Hoffmann-La Roche Ltd Company Profile
-
14.1.2 F Hoffmann-La Roche Ltd Myotonic Dystrophy Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Valentia Biopharma SL
-
14.2.1 Valentia Biopharma SL Company Profile
-
14.2.2 Valentia Biopharma SL Myotonic Dystrophy Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 BioMarin Pharmaceutical Inc
-
14.3.1 BioMarin Pharmaceutical Inc Company Profile
-
14.3.2 BioMarin Pharmaceutical Inc Myotonic Dystrophy Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Genzyme Corporation
-
14.4.1 Genzyme Corporation Company Profile
-
14.4.2 Genzyme Corporation Myotonic Dystrophy Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Isis Pharmaceuticals, Inc
-
14.5.1 Isis Pharmaceuticals, Inc Company Profile
-
14.5.2 Isis Pharmaceuticals, Inc Myotonic Dystrophy Drug Market Performance
-
14.5.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Myotonic Dystrophy Drug Industry Research Conclusions
-
15.2 Myotonic Dystrophy Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Myotonic Dystrophy Drug Industry Market Size (2018-2029)
-
Figure China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of ISIS-DMPKRx (2018-2029)
-
Figure China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of PRO-135 (2018-2029)
-
Figure China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of SRT-152 (2018-2029)
-
Figure China Myotonic Dystrophy Drug Production Volume, Production Value and Growth Rate of VAL-0411 (2018-2029)
-
Figure China Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate of Home Use (2018-2029)
-
Figure China Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure North China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Myotonic Dystrophy Drug Market Size and Growth Rate from 2018-2029
-
Figure Myotonic Dystrophy Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Myotonic Dystrophy Drug Market Share by Type in 2018
-
Figure China Myotonic Dystrophy Drug Market Share by Type in 2023
-
Figure China Myotonic Dystrophy Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Myotonic Dystrophy Drug Production Volume and Growth Rate of ISIS-DMPKRx (2018-2023)
-
Figure China Myotonic Dystrophy Drug Production Volume and Growth Rate of PRO-135 (2018-2023)
-
Figure China Myotonic Dystrophy Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Myotonic Dystrophy Drug Production Volume and Growth Rate of SRT-152 (2018-2023)
-
Figure China Myotonic Dystrophy Drug Production Volume and Growth Rate of VAL-0411 (2018-2023)
-
Figure China Myotonic Dystrophy Drug Market Share by Application in 2018
-
Figure China Myotonic Dystrophy Drug Market Share by Application in 2023
-
Figure China Myotonic Dystrophy Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Myotonic Dystrophy Drug Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Myotonic Dystrophy Drug Market Size and Growth Rate of Home Use (2018-2023)
-
Figure China Myotonic Dystrophy Drug Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Myotonic Dystrophy Drug Market Size and Growth Rate of Others (2018-2023)
-
Table China Myotonic Dystrophy Drug Production Volume by Region (2018-2023)
-
Table China Myotonic Dystrophy Drug Production Volume Share by Region (2018-2023)
-
Figure China Myotonic Dystrophy Drug Production Volume Share by Region (2018-2023)
-
Table China Myotonic Dystrophy Drug Production Value by Region (2018-2023)
-
Table China Myotonic Dystrophy Drug Production Value Share by Region (2018-2023)
-
Figure China Myotonic Dystrophy Drug Production Value Share by Region (2018-2023)
-
Table China Myotonic Dystrophy Drug Sales Volume by Region (2018-2023)
-
Table China Myotonic Dystrophy Drug Sales Volume Share by Region (2018-2023)
-
Figure China Myotonic Dystrophy Drug Sales Volume Share by Region (2018-2023)
-
Table China Myotonic Dystrophy Drug Sales Value by Region (2018-2023)
-
Table China Myotonic Dystrophy Drug Sales Value Share by Region (2018-2023)
-
Figure China Myotonic Dystrophy Drug Sales Value Share by Region (2018-2023)
-
Table North China Myotonic Dystrophy Drug Production Volume by Type (2018-2023)
-
Table North China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Figure North China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Table North China Myotonic Dystrophy Drug Sales Volume by Application (2018-2023)
-
Table North China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Myotonic Dystrophy Drug Production Volume by Type (2018-2023)
-
Table Central China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Table Central China Myotonic Dystrophy Drug Sales Volume by Application (2018-2023)
-
Table Central China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Table South China Myotonic Dystrophy Drug Production Volume by Type (2018-2023)
-
Table South China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Figure South China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Table South China Myotonic Dystrophy Drug Sales Volume by Application (2018-2023)
-
Table South China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Table East China Myotonic Dystrophy Drug Production Volume by Type (2018-2023)
-
Table East China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Figure East China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Table East China Myotonic Dystrophy Drug Sales Volume by Application (2018-2023)
-
Table East China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Myotonic Dystrophy Drug Production Volume by Type (2018-2023)
-
Table Northeast China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Myotonic Dystrophy Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Myotonic Dystrophy Drug Production Volume by Type (2018-2023)
-
Table Southwest China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Myotonic Dystrophy Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Myotonic Dystrophy Drug Production Volume by Type (2018-2023)
-
Table Northwest China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Myotonic Dystrophy Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Myotonic Dystrophy Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Myotonic Dystrophy Drug Sales Volume Share by Application (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Myotonic Dystrophy Drug Revenue, Price and Gross (2018-2023)
-
Table Valentia Biopharma SL Company Profile
-
Table Valentia Biopharma SL Myotonic Dystrophy Drug Revenue, Price and Gross (2018-2023)
-
Table BioMarin Pharmaceutical Inc Company Profile
-
Table BioMarin Pharmaceutical Inc Myotonic Dystrophy Drug Revenue, Price and Gross (2018-2023)
-
Table Genzyme Corporation Company Profile
-
Table Genzyme Corporation Myotonic Dystrophy Drug Revenue, Price and Gross (2018-2023)
-
Table Isis Pharmaceuticals, Inc Company Profile
-
Table Isis Pharmaceuticals, Inc Myotonic Dystrophy Drug Revenue, Price and Gross (2018-2023)
-
